An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome

NCT03882918 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
141
Enrollment
INDUSTRY
Sponsor class

Stopped Company decision

Conditions

Interventions

Sponsor

Healx AI